tiprankstipranks
Trending News
More News >
Interpace Diagnostics Group (IDXG)
OTHER OTC:IDXG
US Market

Interpace Diagnostics Group (IDXG) Financial Statements

Compare
413 Followers

Interpace Diagnostics Group Financial Overview

Interpace Diagnostics Group's market cap is currently $5.34M. The company's EPS TTM is $0.033; its P/E ratio is 4.46; Interpace Diagnostics Group is scheduled to report earnings on November 12, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue$ 46.93M$ 40.21M$ 31.84M$ 41.31M$ 32.40M
Gross Profit$ 29.93M$ 23.90M$ 18.23M$ 17.95M$ 10.72M
Operating Income$ 8.11M$ 2.80M$ -3.84M$ -11.74M$ -26.55M
EBITDA$ 8.36M$ 3.84M$ -2.27M$ -1.33M$ -20.10M
Net Income$ 6.70M$ 802.00K$ -5.87M$ -14.75M$ -26.20M
Balance Sheet
Cash & Short-Term Investments$ 1.46M$ 3.50M$ 4.83M$ 3.31M$ 2.77M
Total Assets$ 14.79M$ 13.02M$ 15.98M$ 38.43M$ 45.68M
Total Debt$ 5.86M$ 11.19M$ 16.09M$ 13.72M$ 4.74M
Net Debt$ 4.39M$ 7.69M$ 11.26M$ 10.40M$ 1.97M
Total Liabilities$ 17.01M$ 28.16M$ 79.05M$ 80.84M$ 74.76M
Stockholders' Equity$ -2.22M$ -15.14M$ -63.07M$ -42.42M$ -29.08M
Cash Flow
Free Cash Flow$ 3.77M$ 3.32M$ -8.01M$ -9.07M$ -16.15M
Operating Cash Flow$ 4.65M$ 3.79M$ -7.69M$ -8.72M$ -14.58M
Investing Cash Flow$ -876.00K$ -87.00K$ 6.21M$ -315.00K$ -1.57M
Financing Cash Flow$ -5.81M$ -5.03M$ 3.00M$ 8.98M$ 16.61M
Currency in USD

Interpace Diagnostics Group Earnings and Revenue History

Interpace Diagnostics Group Debt to Assets

Interpace Diagnostics Group Cash Flow

Interpace Diagnostics Group Forecast EPS vs Actual EPS